A University of Queensland spin-off company is about to start clinical trials that could result in the prevention and treatment of genital herpes, a virus that affects hundreds of thousands of people, threatens newborn...
A combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor, according to Moffitt Cancer Center research. Peter A...
While public health officials around the world are on alert about the pandemic potential of new disease threats, a team that includes Penn State University biologist Marcel Salathé is developing innovative new systems...
A new study reveals that all children with Crohn’s disease that were examined had a commonly occurring virus – an enterovirus – in their intestines. This link has previously not been shown for this chronic inflammatory...
In the light of Novel Corona Virus, concerns over H7N9 Influenza in S.E. Asia, and more familiar infections such as measles and seasonal influenza, it is as important as ever to be able to predict and understand how...
Patients in Vietnam and other locations with central nervous system infections may well be suffering from the effects of a newly discovered virus, according to a study to be published in mBio®, the online open-access...
Modified dendritic cells that can recognize cancer-made protein fragments have shown promise in a small clinical trial studying melanoma. Duke University’s Scott Pruitt, M.D., Ph.D., also of Merck Research Laboratories...
Scientists are reporting progress in the search for the first broad-spectrum drugs to combat human rhinoviruses (HRVs), which cause humanity’s most common infectious diseases. Their study on these potential drugs...
A vaccine which uses ‘gold dust’ to boost the immune system has been developed by scientists. The technique sees tiny gold particles used to mimic a virus and carry proteins to immune cells in the body. Traditional...
A new kind of so-called ‘reverse’ vaccine built to dial down the autoimmune reaction that causes type-1 diabetes is showing promise, a study of 80 patients given once-weekly injections of the vaccine for 12 weeks...